Pharmacokinetic interaction between valproic acid and meropenem;Interacción farmacocinética entre ácido valproico y meropenem

Anales de Pediatria

Volumn 64, Issue 1, 2006, Pages 93-95

  Sala Pinol F ^a   Padulles Zamora N ^a   Hidalgo Albert, E ^a   Clemente Bautista, S ^a   Cabanas Poy M J ^a   Oliveras Arenas, M ^a   Balcells Ramirez J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Meropenem; Pharmacokinetic interaction; Therapeutic levels; Valproic acid

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CHLORAL HYDRATE; IMMUNOGLOBULIN; MEROPENEM; PHENYTOIN; PIRACETAM; TETRACOSACTIDE; VALPROIC ACID; VANCOMYCIN;

ARTICLE; BENIGN CHILDHOOD EPILEPSY; CASE REPORT; DRUG BLOOD LEVEL; DRUG CROSS REACTIVITY; DRUG MECHANISM; DRUG SUBSTITUTION; EPILEPSY; FEMALE; HUMAN; MALE; PATIENT MONITORING; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 33644513114     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13083841     Document Type: Article

References (17)

1. Ficha técnica de Meronem®. Laboratorio AstraZeneca. 2002.
2. a ed. Barcelona: Pharma Editores; 2003.
3. #CO#, Trudeau T, Goldwire M, Wanke LA and Drugdex® Editorial Staff. Valproic Acid (Drug Evaluation Monografh). En: Drugdex Information System. Engleewod, Colorado: Micromedex Inc.; 2005. Vol 124.
4. a ed. Barcelona: Pharma Editores; 2004.
5. a ed. Ohio: Lexi-Comp; 2004. p. 58, 91, 133, 258, 265, 335, 417-9.
6. Nagai K, Shimizu T, Togo A, Takeya M, Yokomizo Y, Sakata Y, et al. Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipron. J Antimicrob Chemother. 1995;39:295-6.
7. Yamagata T, Momoi MY, Murai K, Ikematsu K, Suwa K, Sakamoto K, et al. Panipenem-betamipron and decreases in serum valproic acid concentration. Ther Drug Moni. 1998;20:396-400.
8. De Turck BJ, Diltoer MW, Cornelis PJ, Maes V, Spapen HD, Camu F, et al. Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin. J Antimicrob Chemother. 1998;42:563-4.
9. Linares F, Bosacoma N, Hernández C, Climent E, Selva J, Ordovás JP. Interacción farmacicinética entre ácido valproico y antibióticos carbapenémicos: descripción de tres casos. Farm Hosp. 2003;27:258-63.
10. Pérez A, Soy D, Nicolas JM. Interacción farmacocinética entre el ácido valproico y el meropenem. Med Clin (Barc). 2004;123: 38-9.
11. Nacarkucuk E, Saglam H, Okan M. Meropenem decreases serum level of valproic acid. Pediatr Neurol. 2004;31:232-4.
12. Hobara N, Kameya H, Hokama N, Oshiro S. Altered pharmacokinetics of sodium valproate by simultaneous administration with imipenem/cilastatin sodium. Jpn Hosp Pharm. 1998;24: 464-72.
13. Kojima S, Nadai M, Kitaichi K, Wang L, Nabeshima T, Hasegawa T. Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasama in rats. Antimicrob Agents Chemother. 1998;42: 3163-40.
14. Yamamura N, Imura K, Naganuma H, Nishimura K. Panpenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administred valproic acid in rats. Drug Metab Disp. 1999;27:724-30.
15. Yamamura N, Imura-Myoshi K, Naganuma H. Panipenum, a carbapenem antibiotic, increases the level of hepatic UDP-Glucuronic acid in rats. Drug Metab Disp. 2000;28:1484-6.
16. Yokogawa K, Twashita S, Kubota A, Sasaki Y, Ishizaki J, Kawahara M, et al. Effect of meropenem on disposition of valproate and its metabolites in rabbits. Pharm Res. 2001;18: 1320-6.
17. Nakajima Y, Mizobuchi M, Nakamura M, Takagi H, Inagaki H, Kominami G, et al. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats. Drug Metab Disp. 2004.